Metraipolis › archive › dc_167fe7fa1f5c
Longitudinal IgG antibody responses to Plasmodium vivax blood-stage antigens during and after acute vivax malaria in individuals living in the Brazilian Amazon — Europe PMC PMID:36417454
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/36417454
- DOI
- 10.1371/journal.pntd.0010773
- License (as archived)
- CC0-1.0
- Archived
- 2026-10-15T15:59:11.806Z
- SHA-256 of the archived text
78efebe20cf5dd2cb2e4c3220cd5394d686955ea3f8e928082c518b589da444a- Stable URL of this page
https://metraipolis.com/documento/dc_167fe7fa1f5c
How to cite
Longitudinal IgG antibody responses to Plasmodium vivax blood-stage antigens during and after acute vivax malaria in individuals living in the Brazilian Amazon — Europe PMC PMID:36417454 — Europe PMC (en), https://europepmc.org/article/MED/36417454 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_167fe7fa1f5c (Metraipolis archive dc_167fe7fa1f5c, sha256 78efebe20cf5dd2cb2e4c3220cd5394d686955ea3f8e928082c518b589da444a)
BibTeX
@misc{dc167fe7fa1f5c,
title = {Longitudinal IgG antibody responses to Plasmodium vivax blood-stage antigens during and after acute vivax malaria in individuals living in the Brazilian Amazon — Europe PMC PMID:36417454},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/36417454},
note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_167fe7fa1f5c; sha256 78efebe20cf5dd2cb2e4c3220cd5394d686955ea3f8e928082c518b589da444a},
year = {2026}
}Archived text
Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/36417454. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
Background: To make progress towards malaria elimination, a highly effective vaccine targeting Plasmodium vivax is urgently needed. Evaluating the kinetics of natural antibody responses to vaccine candidate antigens after acute vivax malaria can inform the design of serological markers of exposure and vaccines. Methodology/principal findings: The responses of IgG antibodies to 9 P. vivax vaccine candidate antigens were evaluated in longitudinal serum samples from Brazilian individuals collected at the time of acute vivax malaria and 30, 60, and 180 days afterwards. Antigen-specific IgG correlations, seroprevalence, and half-lives were determined for each antigen using the longitudinal data. Antibody reactivities against Pv41 and PVX_081550 strongly correlated with each other at each of the four time points. The analysis identified robust responses in terms of magnitude and seroprevalence against Pv41 and PvGAMA at 30 and 60 days. Among the 8 P. vivax antigens demonstrating >50% seropositivity across all individuals, antibodies specific to PVX_081550 had the longest half-life (100 days; 95% CI, 83-130 days), followed by PvRBP2b (91 days; 95% CI, 76-110 days) and Pv12 (82 days; 95% CI, 64-110 days). Conclusion/significance: This study provides an in-depth assessment of the kinetics of antibody responses to key vaccine candidate antigens in Brazilians with acute vivax malaria. Follow-up studies are needed to determine whether the longer-lived antibody responses induced by natural infection are effective in controlling blood-stage infection and mediating clinical protection. Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera). Pubblicazione: PLoS neglected tropical diseases, 2022 (prima pubblicazione 2022-11-23). Identificativi: PMID 36417454 · PMCID PMC9728838 · DOI 10.1371/journal.pntd.0010773. Descrittori MeSH principali: Immunoglobulin G; Vaccines. Pagina: https://europepmc.org/article/MED/36417454 — https://doi.org/10.1371/journal.pntd.0010773. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito). Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0. Letto il 2026-10-15T15:21:01.147Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.